Sex differences in cell type-specific transcriptional programs and GPCR signaling in the human subgenual anterior cingulate cortex
- 1University of Pittsburgh
Abstract
Psychiatric conditions show marked sex differences in disease onset, symptom presentation, and response to treatments. Understanding how sex differences manifest across molecularly distinct neuronal populations in individuals without psychiatric conditions may help explain sex-dependent variation in neural circuit function and treatment response. Here, we examined molecularly distinct cell types within the subgenual anterior cingulate cortex (sgACC) of non-psychiatric subjects. Using RNA sequencing data previously generated from laser-capture microdissected neurons, we investigated sex differences in gene expression and co-expression networks in excitatory pyramidal neurons (layers 2/3 and 5/6) and somatostatin (SST)-, parvalbumin (PVALB)-, and vasoactive intestinal peptide (VIP)-expressing inhibitory interneurons (N=10 males, 9 females). We identified sex differences in transcriptomic profiles, biological pathways, and co-expression network connectivity. PVALB cells showed stronger overall female transcriptional enrichment, while SST cells exhibited male-enriched transcriptional signatures. Weighted gene co-expression network analysis identified PVALB and SST modules more connected in males and females, respectively, which included hub genes involved in immune, extracellular matrix, and bioenergetic processes. Since G protein-coupled receptors (GPCRs) are viable therapeutic targets, we examined sex differences in GPCR transcripts. Across all GPCR-cell-type combinations, CHRM2 in PVALB cells showed the second strongest sex difference (enriched in females). To test the functional relevance of this difference, we used patch-clamp electrophysiology in mouse prefrontal cortex. M2 receptor activation increased maximal firing rates in PVALB cells from female but not male mice. Collectively, our findings demonstrate cell type-specific sex differences in the sgACC corresponding to functional differences in neuromodulator signaling, with potential implications for treatment response.
Related
- Sex-biased enhancers shape transcriptional sex differences across human tissues
- Transcriptional differences between repeatedly recultured and freshly induced embryogenic calli reveal candidate developmental regulators
- Exogenous Melatonin Alleviates High- and Low-Temperature Stress in Cucumber Seedlings and Regulates Hormone Signaling-Related Transcriptional Responses
- Temporal patterns of melanopsin-evoked calcium signaling engage NF-κB-associated transcriptional and phosphoproteomic responses
- Multicellular Perturb-seq Reveals Lineage-Specific Transcriptional Control During Human Cardiac Organoid Development
BibTeX
@misc{snowden2026differences,
title = {{Sex differences in cell type-specific transcriptional programs and GPCR signaling in the human subgenual anterior cingulate cortex}},
author = {A. W. Snowden and N. Y. Li and E. Sibille and M. E. Joffe and M. L. Seney},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.04.763991},
url = {https://www.biorxiv.org/content/10.64898/2026.11.04.763991v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Sex differences in cell type-specific transcriptional programs and GPCR signaling in the human subgenual anterior cingulate cortex
AU - A. W. Snowden
AU - N. Y. Li
AU - E. Sibille
AU - M. E. Joffe
AU - M. L. Seney
PY - 2026
DA - 2026/11/04
PB - bioRxiv
DO - 10.64898/2026.11.04.763991
UR - https://www.biorxiv.org/content/10.64898/2026.11.04.763991v1
AB - Psychiatric conditions show marked sex differences in disease onset, symptom presentation, and response to treatments. Understanding how sex differences manifest across molecularly distinct neuronal populations in individuals without psychiatric conditions may help explain sex-dependent variation in neural circuit function and treatment response. Here, we examined molecularly distinct cell types within the subgenual anterior cingulate cortex (sgACC) of non-psychiatric subjects. Using RNA sequencing data previously generated from laser-capture microdissected neurons, we investigated sex differences in gene expression and co-expression networks in excitatory pyramidal neurons (layers 2/3 and 5/6) and somatostatin (SST)-, parvalbumin (PVALB)-, and vasoactive intestinal peptide (VIP)-expressing inhibitory interneurons (N=10 males, 9 females). We identified sex differences in transcriptomic profiles, biological pathways, and co-expression network connectivity. PVALB cells showed stronger overall female transcriptional enrichment, while SST cells exhibited male-enriched transcriptional signatures. Weighted gene co-expression network analysis identified PVALB and SST modules more connected in males and females, respectively, which included hub genes involved in immune, extracellular matrix, and bioenergetic processes. Since G protein-coupled receptors (GPCRs) are viable therapeutic targets, we examined sex differences in GPCR transcripts. Across all GPCR-cell-type combinations, CHRM2 in PVALB cells showed the second strongest sex difference (enriched in females). To test the functional relevance of this difference, we used patch-clamp electrophysiology in mouse prefrontal cortex. M2 receptor activation increased maximal firing rates in PVALB cells from female but not male mice. Collectively, our findings demonstrate cell type-specific sex differences in the sgACC corresponding to functional differences in neuromodulator signaling, with potential implications for treatment response.
ER -